Latest return on equity
Amphastar Pharmaceuticals Return on equity
Direct answer
Amphastar Pharmaceuticals's return on equity is 10.3%.
The verified market snapshot reports 10.3%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 10.3%
Explore related company data
View Amphastar Pharmaceuticals's market capitalizationView Amphastar Pharmaceuticals's p/e ratioView Amphastar Pharmaceuticals's price-to-book ratioView Amphastar Pharmaceuticals's dividend yieldView Amphastar Pharmaceuticals's 52-week price rangeView Amphastar Pharmaceuticals's revenue growthView Amphastar Pharmaceuticals's profit marginView Amphastar Pharmaceuticals's debt-to-equity ratioView all Amphastar Pharmaceuticals key metricsReturn to Amphastar Pharmaceuticals profile